Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 34
1993 15
1994 27
1995 38
1996 54
1997 80
1998 91
1999 158
2000 175
2001 230
2002 246
2003 308
2004 288
2005 341
2006 346
2007 309
2008 316
2009 320
2010 347
2011 361
2012 424
2013 516
2014 497
2015 560
2016 555
2017 594
2018 591
2019 645
2020 739
2021 751
2022 788
2023 791
2024 787
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11,182 results

Results by year

Filters applied: . Clear all
Page 1
Levofloxacin-Associated Encephalopathy.
Kumabe A, Kenzaka T. Kumabe A, et al. Am J Ther. 2023 Nov-Dec 01;30(6):e549-e550. doi: 10.1097/MJT.0000000000001615. Epub 2023 Feb 27. Am J Ther. 2023. PMID: 36848632 No abstract available.
[Legionella and Legionellosis].
Kolditz M, Lück C. Kolditz M, et al. Dtsch Med Wochenschr. 2019 Aug;144(15):1030-1033. doi: 10.1055/a-0662-9330. Epub 2019 Jul 26. Dtsch Med Wochenschr. 2019. PMID: 31350743 German.
This might at least partially be due to more frequently used diagnostic tests.In severe pneumonia, nucleic acid amplification based methods should supplement the L. pneumophila serogroup-1 urinary antigen test because of their improved spectrum and sensitivity.Recent in vitro dat …
This might at least partially be due to more frequently used diagnostic tests.In severe pneumonia, nucleic acid amplification based methods …
Levofloxacin in veterinary medicine: a literature review.
Sitovs A, Sartini I, Giorgi M. Sitovs A, et al. Res Vet Sci. 2021 Jul;137:111-126. doi: 10.1016/j.rvsc.2021.04.031. Epub 2021 Apr 30. Res Vet Sci. 2021. PMID: 33964616 Review.
A potent third-generation antimicrobial fluoroquinolone drug, levofloxacin was introduced into human clinical practice in 1993. Levofloxacin is also used in veterinary medicine, however its use is limited: it is completely banned for veterinary use in the EU, and us …
A potent third-generation antimicrobial fluoroquinolone drug, levofloxacin was introduced into human clinical practice in 1993. Le …
Primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region between 1990 and 2022: an updated systematic review and meta-analysis.
Hong TC, El-Omar EM, Kuo YT, Wu JY, Chen MJ, Chen CC, Fang YJ, Leow AHR, Lu H, Lin JT, Tu YK, Yamaoka Y, Wu MS, Liou JM; Asian Pacific Alliance on Helicobacter and Microbiota. Hong TC, et al. Lancet Gastroenterol Hepatol. 2024 Jan;9(1):56-67. doi: 10.1016/S2468-1253(23)00281-9. Epub 2023 Nov 14. Lancet Gastroenterol Hepatol. 2024. PMID: 37972625
Studies investigating primary H pylori resistance to clarithromycin, metronidazole, levofloxacin, amoxicillin, or tetracycline in individuals naive to eradication therapy in the Asia-Pacific region (as defined by the UN geoscheme) were eligible for inclusion. ...From 1990 …
Studies investigating primary H pylori resistance to clarithromycin, metronidazole, levofloxacin, amoxicillin, or tetracycline in ind …
Levofloxacin-induced crystal nephropathy.
Liu Y, He Q, Wu M. Liu Y, et al. Nephrology (Carlton). 2015 Jun;20(6):437-8. doi: 10.1111/nep.12405. Nephrology (Carlton). 2015. PMID: 25900386 No abstract available.
Levofloxacin for the treatment of pyelonephritis.
Rafat C, Debrix I, Hertig A. Rafat C, et al. Expert Opin Pharmacother. 2013 Jun;14(9):1241-53. doi: 10.1517/14656566.2013.792805. Epub 2013 Apr 24. Expert Opin Pharmacother. 2013. PMID: 23614756 Review.
AREAS COVERED: This review covers the medical literature in any language through December 2012, on 'levofloxacin'. To identify relevant articles, the search terms 'pyelonephritis', 'urinary tract infections', 'levofloxacin', 'levaquin' and 'ofloxacin' were obtained …
AREAS COVERED: This review covers the medical literature in any language through December 2012, on 'levofloxacin'. To identify releva …
The treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children.
Dai FF, Liu FQ, Chen X, Yang J, Wang K, Guo CY. Dai FF, et al. J Clin Pharm Ther. 2021 Jun;46(3):705-710. doi: 10.1111/jcpt.13331. Epub 2021 Jan 6. J Clin Pharm Ther. 2021. PMID: 33403672
WHAT IS NEW AND CONCLUSION: The clinical symptoms and imaging significantly improved after treatment with levofloxacin, and no drug-related adverse reactions were observed. Levofloxacin proved to be an effective and safe drug in the treatment of children with macrol …
WHAT IS NEW AND CONCLUSION: The clinical symptoms and imaging significantly improved after treatment with levofloxacin, and no drug-r …
Pharmacokinetic/pharmacodynamic-based optimization of levofloxacin administration in the treatment of MDR-TB.
Ghimire S, Van't Boveneind-Vrubleuskaya N, Akkerman OW, de Lange WC, van Soolingen D, Kosterink JG, van der Werf TS, Wilffert B, Touw DJ, Alffenaar JW. Ghimire S, et al. J Antimicrob Chemother. 2016 Oct;71(10):2691-703. doi: 10.1093/jac/dkw164. Epub 2016 May 26. J Antimicrob Chemother. 2016. PMID: 27231277 Review.
Among the 32 adult studies, 19 were on susceptibility of Mycobacterium tuberculosis isolates to levofloxacin by MIC, 1 was on susceptibility of M. tuberculosis isolates to levofloxacin by MBC, 1 was on susceptibility of M. tuberculosis isolates to levofloxacin …
Among the 32 adult studies, 19 were on susceptibility of Mycobacterium tuberculosis isolates to levofloxacin by MIC, 1 was on suscept …
Acute pancreatitis associated with levofloxacin.
Jiménez Moreno MA, Hontoria Bautista G, Pereda García R. Jiménez Moreno MA, et al. Rev Esp Enferm Dig. 2020 Jun;112(6):510. doi: 10.17235/reed.2020.6652/2019. Rev Esp Enferm Dig. 2020. PMID: 32496110 Free article.
According to some series, 0.3-1.5% of all cases of acute pancreatitis are drug induced. Acute pancreatitis due to levofloxacin is included in its safety data sheet as an adverse effect....
According to some series, 0.3-1.5% of all cases of acute pancreatitis are drug induced. Acute pancreatitis due to levofloxacin is inc …
A multicentre, randomised, double-blind, double-dummy, parallel-controlled, phase 3 clinical trial assessing the efficacy and safety of intravenous nemonoxacin malate vs. levofloxacin for community-acquired pneumonia in adult patients.
Li Y, Zhu D, Sun S, Chang X, Cao Z, Yang Y, Fu X, Li X, Xu J, Zhu Y, Hui F, Xu X, Chen Z, Peng L, Ma Z, Mo B, Li C, Lv Y, Zhao L, Zhu G, He Y, Liu H, Chen J, Wang Y, Liang Y, Lu Y, Qin Z, Yang H, Zhang M, Wu S, Tong Z, Ye F, Xiao Z, Wang X, Qiu C, Kuang J, Huang H, Wang K, Ying K, Jin F, Lv X, Huang Y, Liu D, Wang W, Zhang Y. Li Y, et al. Int J Antimicrob Agents. 2024 Aug;64(2):107235. doi: 10.1016/j.ijantimicag.2024.107235. Epub 2024 Jun 6. Int J Antimicrob Agents. 2024. PMID: 38851462 Free article. Clinical Trial.
Secondary efficacy and safety were also compared between nemonoxacin and levofloxacin. RESULTS: Overall, 525 patients were randomised and treated with nemonoxacin (n = 349) or levofloxacin (n = 176). The clinical cure rate was 91.8% (279/304) for nemonoxacin and 85. …
Secondary efficacy and safety were also compared between nemonoxacin and levofloxacin. RESULTS: Overall, 525 patients were randomised …
11,182 results
You have reached the last available page of results. Please see the User Guide for more information.